跳至主要内容
临床试验/NCT04057482
NCT04057482已完成不适用

Treatment of Bacterial Vaginosis With Dequalinium Chloride Vaginal Tablets and a Test of Cure Using a New Molecular Diagnostic Test for the Diagnosis of Bacterial Vaginosis

Skaraborg Hospital0 个研究点目标入组 58 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
58
主要终点
cure rate of BV

研究概览

简要总结

. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.

详细描述

This is the first study to utilize a molecular diagnostic test as a test of cure for bacterial vaginosis. The Nugent score is a reliable method for diagnosing bacterial vaginosis, but similar to traditional clinical diagnostic methods, it is not equally reliable when utilized as a test of cure. This study demonstrated that molecular diagnostic testing can be used as a test of cure and this is the first molecular test that can do that. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • No other infection (Gc, clhlamydia, trihomonas)

结局指标

主要结局

cure rate of BV

时间窗: 1 year

how many that are cured of BV after 1 month

次要结局

  • Diagnosis of BV using molecular test(1 year)

研究者

发起方
Skaraborg Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Per-Goran Larsson

professor

Skaraborg Hospital

相似试验

Treatment of BV With Donaxyl and a Molecular Test of... | 临床试验